Latest News

Testing Parkinson's disease immune-based drugs: New models

Using powerful, newly developed cell culture and mouse models of sporadic Parkinson?s disease (PD), researchers have demonstrated that immunotherapy with specifically targeted antibodies may block the development and spread of PD pathology in the brain. By intercepting the distorted and misfolded alpha-synuclein (?-syn) proteins that enter and propagate in neurons, creating aggregates, the researchers prevented the development of pathology and also reversed some of the effects of already-existing disease.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Psychotic patients distinguished from controls while watching movie Alice in Wonderland

  • Clinical trial shows first treatment for ?emotional flatness? associated with schizophrenia

  • Food may be addictive: Food craving may be 'hard-wired' in the brain

  • Testosterone changes brain structures in female-to-male transsexuals

  • Cold weather associated with higher risk of severe heart attack

  • Cold weather linked to increased stroke risk in atrial fibrillation patients

  • How can we prevent suicide? Major study shows risk factors associated with depression

  • Scientists show how magnetic pulses change the brain in treatment for depressed patients

  • A single cocaine dose lowers perceptions of sadness and anger

  • Better signs could help reduce friction between motorists, bicyclists

  •